Kari Hemminki

Medicine & Life Sciences

1. Sweden 100%
2. Neoplasms 69%
3. Incidence 47%
4. Second Primary Neoplasms 44%
5. Genome-Wide Association Study 32%
6. Survival 30%
7. Single Nucleotide Polymorphism 29%
8. Colorectal Neoplasms 28%
9. Siblings 27%
10. Multiple Myeloma 26%
11. Autoimmune Diseases 25%
12. Breast Neoplasms 25%
13. Population 23%
14. Genes 22%
15. Databases 20%
16. Histology 19%
17. Melanoma 18%
18. Prostatic Neoplasms 16%
19. Hospitalization 15%
20. Cluster Analysis 13%
21. Non-Hodgkin's Lymphoma 13%
22. Registries 13%
23. Familial Breast Cancer 13%
24. Lung Neoplasms 12%
25. Cohort Studies 12%
26. Alleles 12%
27. Thyroid Neoplasms 11%
28. Parents 11%
29. Hodgkin Disease 11%
30. Odds Ratio 11%
31. Confidence Intervals 10%
32. Skin Neoplasms 10%
33. Neoplasm Metastasis 10%
34. Chromosome Aberrations 9%
35. Urinary Bladder Neoplasms 9%
36. Genetic Predisposition to Disease 9%
37. Epidemiologic Studies 9%
38. Testicular Neoplasms 8%
39. Precursor Cell Lymphoblastic Leukemia-Lymphoma 8%
40. Adenocarcinoma 8%
41. Endometrial Neoplasms 8%
42. Ovarian Neoplasms 8%
43. Spouses 8%
44. Genetic Variation 8%
45. Telomerase 7%
46. Kidney Neoplasms 7%
47. Cause of Death 7%
48. Cutaneous Malignant Melanoma 7%
49. Nervous System Neoplasms 7%
50. Mutation 7%